Term
| impaired fasting glucose: |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| A1c% goal for DM patients in general: |
|
Definition
|
|
Term
| less stringent A1c goals may be appropriate for: |
|
Definition
1. pt @ risk for hypoglycemia
2. limited life expectancy
3. chronic DM on multiple Rx and still have A1c>7% |
|
|
Term
| Each 1% drop in A1c decreases microvasculat changes by: |
|
Definition
|
|
Term
| goal for preprandial capillary glu: |
|
Definition
|
|
Term
| goal for peak post prandial capillary glu: |
|
Definition
|
|
Term
| goals for GDM for preprandial, 1&2Hr postprandial capillary GLu: |
|
Definition
preprandial <95
1Hr post prandial <140
2Hr post prandial <120 |
|
|
Term
| a 1% change in A1c above 5% corresponds to an avg BG of: |
|
Definition
|
|
Term
| A1c level diagnostic for DM: |
|
Definition
|
|
Term
| fasting BG diagnostic for DM |
|
Definition
|
|
Term
| random BG diagnostic for DM: |
|
Definition
|
|
Term
| OGTT result diagnostic for DM: |
|
Definition
| 2hr GTT value greater than 200 |
|
|
Term
| 3 types of autoimmune markers for type 1 DM: |
|
Definition
1. GAD-65
2. islet cell Ag-2
3. insulin autoantibodies |
|
|
Term
| autoantibody that is present in nearly all adult onset T1DM: |
|
Definition
|
|
Term
|
Definition
1. IFG/IGTT
2. age>55
3. race (minority) |
|
|
Term
| Tx of choice for prediabetes: |
|
Definition
|
|
Term
| indications for meds in prediabetes:7 |
|
Definition
1. IFG/IGT
2. A1c>6%
3. HTN
4. Obese
5. Fhx DM
6. <60yo
7. dyslipidemia |
|
|
